Compact viral RNA sequences boost mRNA stability and protein output
Researchers at the Institute for Basic Science, led by Director Kim V. Narry, have identified small RNA elements from viruses that enhance the stability of mRNA and increase protein production. These elements offer a straightforward approach to creating more durable and effective mRNA-based vaccines and therapeutics. The discovery could lead to longer-lasting treatments with improved efficiency.
The research team at the Institute for Basic Science, under the leadership of Director Kim V. Narry, has uncovered that specific compact RNA sequences originating from viruses can shield messenger RNA from rapid breakdown. This protective action allows the mRNA to remain active for longer periods, resulting in a greater quantity of the target protein being synthesized within cells.
Because these viral elements are notably small, they can be seamlessly incorporated into existing mRNA designs. This provides a practical, low-complexity method to extend the functional lifespan of mRNA-based products, potentially simplifying production and enhancing the overall durability of future vaccines and therapeutic treatments.
This advancement could significantly influence the medical field by enabling mRNA vaccines and therapies to remain effective for extended durations. Patients may require fewer booster shots or lower dosages, reducing the burden on healthcare systems. Pharmaceutical developers could also benefit from improved product shelf-life, potentially lowering costs and easing distribution challenges, especially in regions with limited cold-chain infrastructure. However, rigorous clinical testing will be necessary to confirm these benefits in real-world applications.